• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化氮供体型化合物的抗肿瘤活性。

Antitumoral Activity Of Nitric Oxide-Releasing Compounds.

机构信息

Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.

出版信息

Redox Biol. 2015 Aug;5:420. doi: 10.1016/j.redox.2015.09.031. Epub 2015 Dec 30.

DOI:10.1016/j.redox.2015.09.031
PMID:28162287
Abstract

BACKGROUND

Despite significant improvements in the conventional anti-ovarian cancer therapies, tumor cell resistance to various cytostatic drugs remains a relevant problem. Therefore, the new cancer treatment strategies are being developed. Among many agents that have been studied for their potential anti-cancer activity, the most promising are the nitric oxide (NO) donors-syntethic compounds that release NO in vivo and/or in vitro.

AIM

We have evaluated the effect of NO donors on the SK-OV-3 and OVCAR-3 ovarian cancer cell lines. We assessed some of the cancer cells' specific features: the uncontrolled proliferation, over-activation of particular signaling proteins, high resistance to therapeutics and elevated expression and secretion of invasiveness/metastatic factors.

METHODS

Two members of NONOates family were used: SPER/NO and DETA/NO. Cancer cell lines were cultured with different concentrations of NO donors. The cytotoxic, pro-apoptotic activity of NO donors and their impact on the phosphorylation status of STAT-3 and AKT in cells were determined. The expression of VEGF-A, MMPs and TGF-β was also evaluated.

RESULTS

NO donors inhibited ovarian cancer cells growth making them also more susceptible to the cisplatin cytotoxic activity. Moreover, both NO donors induced apoptosis of cells and decreased activity of signaling proteins (STAT3 and AKT). Similarly, SPER/NO and DETA/NO lowered the secretion of pro-metastatic factors, responsible for cancer cells invasiveness.

CONCLUSIONS

The obtained results show that both NO donors demonstrated a wide range of action on both ovarian cancer cell lines. Therefore, they have a high potential of being a supporting compounds in the cancer therapies.

摘要

背景

尽管传统的抗卵巢癌疗法有了显著的进步,但肿瘤细胞对各种细胞抑制剂的耐药性仍然是一个相关的问题。因此,新的癌症治疗策略正在被开发。在许多被研究具有潜在抗癌活性的药物中,最有前途的是一氧化氮(NO)供体——合成化合物,它们在体内和/或体外释放 NO。

目的

我们评估了 NO 供体对 SK-OV-3 和 OVCAR-3 卵巢癌细胞系的影响。我们评估了一些癌细胞的特定特征:不受控制的增殖、特定信号蛋白的过度激活、对治疗的高度耐药性以及侵袭性/转移性因子的高表达和分泌。

方法

使用了 NONOates 家族的两个成员:SPER/NO 和 DETA/NO。用不同浓度的 NO 供体培养癌细胞系。测定了 NO 供体的细胞毒性、促凋亡活性及其对细胞中 STAT-3 和 AKT 磷酸化状态的影响。还评估了 VEGF-A、MMPs 和 TGF-β 的表达。

结果

NO 供体抑制卵巢癌细胞生长,使它们对顺铂的细胞毒性更敏感。此外,两种 NO 供体都诱导了细胞凋亡,并降低了信号蛋白(STAT3 和 AKT)的活性。同样,SPER/NO 和 DETA/NO 降低了负责癌细胞侵袭性的促转移因子的分泌。

结论

所得结果表明,两种 NO 供体对两种卵巢癌细胞系均表现出广泛的作用。因此,它们具有成为癌症治疗辅助化合物的高潜力。

相似文献

1
Antitumoral Activity Of Nitric Oxide-Releasing Compounds.一氧化氮供体型化合物的抗肿瘤活性。
Redox Biol. 2015 Aug;5:420. doi: 10.1016/j.redox.2015.09.031. Epub 2015 Dec 30.
2
Nitric oxide donors: spermine/NO and diethylenetriamine/NO induce ovarian cancer cell death and affect STAT3 and AKT signaling proteins.一氧化氮供体:精脒/NO 和二亚乙基三胺/NO 诱导卵巢癌细胞死亡,并影响 STAT3 和 AKT 信号蛋白。
Nitric Oxide. 2013 Nov 30;35:93-109. doi: 10.1016/j.niox.2013.09.001. Epub 2013 Sep 17.
3
Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines.评估一氧化氮供体对各种卵巢癌细胞系顺铂耐药性的影响。
Toxicol In Vitro. 2016 Oct;36:26-37. doi: 10.1016/j.tiv.2016.07.005. Epub 2016 Jul 15.
4
Nitric oxide donors reduce the invasion ability of ovarian cancer cells in vitro.一氧化氮供体在体外降低卵巢癌细胞的侵袭能力。
Anticancer Drugs. 2014 Nov;25(10):1141-51. doi: 10.1097/CAD.0000000000000149.
5
Small molecule inhibitor of c-Met (PHA665752) suppresses the growth of ovarian cancer cells and reverses cisplatin resistance.c-Met小分子抑制剂(PHA665752)可抑制卵巢癌细胞生长并逆转顺铂耐药性。
Tumour Biol. 2016 Jun;37(6):7843-52. doi: 10.1007/s13277-015-4318-x. Epub 2015 Dec 23.
6
XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.X连锁凋亡抑制蛋白(XIAP)在顺铂诱导的人卵巢上皮癌细胞凋亡过程中调节Akt活性和半胱天冬酶-3依赖性切割。
Cancer Res. 2001 Mar 1;61(5):1862-8.
7
A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.一种有效的溶瘤腺病毒选择性地阻断 STAT3 信号通路,并增强顺铂在卵巢癌中的抗肿瘤活性。
Hum Gene Ther. 2012 Jan;23(1):32-45. doi: 10.1089/hum.2011.101. Epub 2011 Oct 14.
8
Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.脂质体顺铂脂质体在卵巢癌中的临床前活性。
Clin Cancer Res. 2014 Nov 1;20(21):5496-506. doi: 10.1158/1078-0432.CCR-14-0713. Epub 2014 Sep 17.
9
Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.假定的癌症干细胞标志物和生长因子受体表达对卵巢癌细胞对各种形式小分子酪氨酸激酶抑制剂和细胞毒性药物治疗敏感性的影响。
Int J Oncol. 2016 Nov;49(5):1825-1838. doi: 10.3892/ijo.2016.3678. Epub 2016 Sep 5.
10
Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.顺铂抑制顺铂耐药卵巢癌细胞系中紫杉醇诱导的细胞凋亡:联合治疗失败的可能原因
Cancer Res. 1999 May 15;59(10):2425-32.